{"id": "article-18332_0", "title": "Bipolar Disorder -- Continuing Education Activity", "content": "Bipolar disorder, also known as bipolar affective disorder, is one of the top 10 leading causes of disability worldwide. Bipolar disorder is characterized by chronically occurring episodes of mania or hypomania alternating with depression and is often misdiagnosed initially. Treatment involves pharmacotherapy and psychosocial interventions, but mood relapse and incomplete response occur, particularly with depression. Continual reevaluation and treatment modification are commonly required during the long-term care of patients with bipolar disorder. Management of comorbid psychiatric and chronic medical conditions may also be necessary. This activity reviews the etiology, classification, evaluation, management, and prognosis of bipolar affective disorder, and it also highlights the role of the interprofessional team in managing and improving care for patients with this condition.", "contents": "Bipolar Disorder -- Continuing Education Activity. Bipolar disorder, also known as bipolar affective disorder, is one of the top 10 leading causes of disability worldwide. Bipolar disorder is characterized by chronically occurring episodes of mania or hypomania alternating with depression and is often misdiagnosed initially. Treatment involves pharmacotherapy and psychosocial interventions, but mood relapse and incomplete response occur, particularly with depression. Continual reevaluation and treatment modification are commonly required during the long-term care of patients with bipolar disorder. Management of comorbid psychiatric and chronic medical conditions may also be necessary. This activity reviews the etiology, classification, evaluation, management, and prognosis of bipolar affective disorder, and it also highlights the role of the interprofessional team in managing and improving care for patients with this condition."}
{"id": "article-18332_1", "title": "Bipolar Disorder -- Continuing Education Activity", "content": "Objectives: Recognize patterns of symptoms suggestive of bipolar disorder, its various subtypes, and related disorders. Implement evidence-based management of bipolar disorder based on current published guidelines. Select individualized pharmacotherapy plans and adjunct therapies for bipolar disorder and comorbidities. Describe the necessity of an interprofessional holistic team approach that integrates psychiatric and medical healthcare in caring for patients with bipolar disorder to help achieve the best possible outcomes. Access free multiple choice questions on this topic.", "contents": "Bipolar Disorder -- Continuing Education Activity. Objectives: Recognize patterns of symptoms suggestive of bipolar disorder, its various subtypes, and related disorders. Implement evidence-based management of bipolar disorder based on current published guidelines. Select individualized pharmacotherapy plans and adjunct therapies for bipolar disorder and comorbidities. Describe the necessity of an interprofessional holistic team approach that integrates psychiatric and medical healthcare in caring for patients with bipolar disorder to help achieve the best possible outcomes. Access free multiple choice questions on this topic."}
{"id": "article-18332_2", "title": "Bipolar Disorder -- Introduction", "content": "Bipolar disorder (BD) is characterized by chronically occurring episodes of mania or hypomania alternating with depression and is often misdiagnosed initially.", "contents": "Bipolar Disorder -- Introduction. Bipolar disorder (BD) is characterized by chronically occurring episodes of mania or hypomania alternating with depression and is often misdiagnosed initially."}
{"id": "article-18332_3", "title": "Bipolar Disorder -- Introduction", "content": "Bipolar and\u00a0related disorders include bipolar I disorder (BD-I), bipolar II disorder (BD-II), cyclothymic disorder, other specified bipolar and related disorders, and bipolar or related disorders, unspecified. The diagnostic label of \"bipolar affective disorders\" in the International Classification of Diseases 10th Revision (ICD-10) was changed to \"bipolar disorders\" in the ICD-11. The section on bipolar disorders in the ICD-11 is labeled \"bipolar and related disorders,\" which is consistent with the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). [1]", "contents": "Bipolar Disorder -- Introduction. Bipolar and\u00a0related disorders include bipolar I disorder (BD-I), bipolar II disorder (BD-II), cyclothymic disorder, other specified bipolar and related disorders, and bipolar or related disorders, unspecified. The diagnostic label of \"bipolar affective disorders\" in the International Classification of Diseases 10th Revision (ICD-10) was changed to \"bipolar disorders\" in the ICD-11. The section on bipolar disorders in the ICD-11 is labeled \"bipolar and related disorders,\" which is consistent with the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). [1]"}
{"id": "article-18332_4", "title": "Bipolar Disorder -- Introduction", "content": "A World Health Organization study showed \"remarkably similar\" international prevalence rates, severity, impact, and comorbidities of bipolar spectrum disorder, defined as BD-I, BD-II, and subthreshold bipolar. The aggregate lifetime prevalence of the bipolar spectrum was 2.4%. [2]", "contents": "Bipolar Disorder -- Introduction. A World Health Organization study showed \"remarkably similar\" international prevalence rates, severity, impact, and comorbidities of bipolar spectrum disorder, defined as BD-I, BD-II, and subthreshold bipolar. The aggregate lifetime prevalence of the bipolar spectrum was 2.4%. [2]"}
{"id": "article-18332_5", "title": "Bipolar Disorder -- Introduction", "content": "BD is often\u00a0difficult to recognize because symptoms overlap with other psychiatric disorders, psychiatric and somatic comorbidity is common, and patients may lack insight into their conditions, particularly hypomania. Treatment involves pharmacotherapy and psychosocial interventions, but mood relapse and incomplete response occur, particularly with depression. Continual reevaluation and treatment modification are commonly required during the long-term care of these patients. Management of comorbid psychiatric and chronic medical conditions may also be necessary. This activity\u00a0provides an overview of the\u00a0etiology, classification, evaluation, and management of bipolar affective disorder.", "contents": "Bipolar Disorder -- Introduction. BD is often\u00a0difficult to recognize because symptoms overlap with other psychiatric disorders, psychiatric and somatic comorbidity is common, and patients may lack insight into their conditions, particularly hypomania. Treatment involves pharmacotherapy and psychosocial interventions, but mood relapse and incomplete response occur, particularly with depression. Continual reevaluation and treatment modification are commonly required during the long-term care of these patients. Management of comorbid psychiatric and chronic medical conditions may also be necessary. This activity\u00a0provides an overview of the\u00a0etiology, classification, evaluation, and management of bipolar affective disorder."}
{"id": "article-18332_6", "title": "Bipolar Disorder -- Etiology", "content": "Currently, the etiology of BD is unknown but appears to be due to an interaction of genetic, epigenetic, neurochemical, and environmental factors. Heritability is well established. [3] [4] [5] Numerous genetic loci have been implicated as increasing the risk of BD; the\u00a0first was noted in 1987 with \"DNA markers\" on the short arm of chromosome 11. Since then, an association has been made between at least 30 genes and an increased risk of the condition. [6]", "contents": "Bipolar Disorder -- Etiology. Currently, the etiology of BD is unknown but appears to be due to an interaction of genetic, epigenetic, neurochemical, and environmental factors. Heritability is well established. [3] [4] [5] Numerous genetic loci have been implicated as increasing the risk of BD; the\u00a0first was noted in 1987 with \"DNA markers\" on the short arm of chromosome 11. Since then, an association has been made between at least 30 genes and an increased risk of the condition. [6]"}
{"id": "article-18332_7", "title": "Bipolar Disorder -- Etiology", "content": "Although it is difficult to establish causation between life events and the development of BD, childhood maltreatment, particularly emotional abuse or neglect, has been linked to the later development of the condition. Other stressful life events associated with developing\u00a0BD include childbirth, divorce, unemployment, disability, and early parental loss. [7] In adulthood, more than 60% of patients with BD\u00a0report at least one \"stressful life event\" before a manic or depressive episode in the preceding\u00a06 months. [6]", "contents": "Bipolar Disorder -- Etiology. Although it is difficult to establish causation between life events and the development of BD, childhood maltreatment, particularly emotional abuse or neglect, has been linked to the later development of the condition. Other stressful life events associated with developing\u00a0BD include childbirth, divorce, unemployment, disability, and early parental loss. [7] In adulthood, more than 60% of patients with BD\u00a0report at least one \"stressful life event\" before a manic or depressive episode in the preceding\u00a06 months. [6]"}
{"id": "article-18332_8", "title": "Bipolar Disorder -- Etiology", "content": "The etiology of\u00a0BD is thought to involve imbalances in systems associated with monoaminergic neurotransmitters, particularly dopamine and serotonin, and intracellular signaling systems that regulate mood. However, no singular dysfunction of these neurotransmitter systems has been identified. [8]", "contents": "Bipolar Disorder -- Etiology. The etiology of\u00a0BD is thought to involve imbalances in systems associated with monoaminergic neurotransmitters, particularly dopamine and serotonin, and intracellular signaling systems that regulate mood. However, no singular dysfunction of these neurotransmitter systems has been identified. [8]"}
{"id": "article-18332_9", "title": "Bipolar Disorder -- Etiology", "content": "In a recent neuroimaging review article, the ENIGMA Bipolar Disorder Working Group\u00a0stated, \"Overall, these studies point to a diffuse pattern of brain alterations including smaller subcortical volumes, lower cortical thickness and altered white matter integrity in groups of individuals with bipolar disorder compared to healthy controls.\" [9] Neuroimaging studies have also shown evidence of changes in functional connectivity. [10] [11]", "contents": "Bipolar Disorder -- Etiology. In a recent neuroimaging review article, the ENIGMA Bipolar Disorder Working Group\u00a0stated, \"Overall, these studies point to a diffuse pattern of brain alterations including smaller subcortical volumes, lower cortical thickness and altered white matter integrity in groups of individuals with bipolar disorder compared to healthy controls.\" [9] Neuroimaging studies have also shown evidence of changes in functional connectivity. [10] [11]"}
{"id": "article-18332_10", "title": "Bipolar Disorder -- Epidemiology", "content": "In the World Mental Health Survey Initiative, the use of mental health services for the bipolar spectrum (BD-I, BD-II, and subthreshold BD) concluded, \u201cDespite cross-site variation in the prevalence rates of bipolar spectrum disorder, the severity, impact, and patterns of comorbidity were remarkably similar internationally.\u201d The aggregate lifetime prevalence of BD-I was 0.6%, BD-II 0.4%, subthreshold BD 1.4%, and bipolar spectrum 2.4%. [2]", "contents": "Bipolar Disorder -- Epidemiology. In the World Mental Health Survey Initiative, the use of mental health services for the bipolar spectrum (BD-I, BD-II, and subthreshold BD) concluded, \u201cDespite cross-site variation in the prevalence rates of bipolar spectrum disorder, the severity, impact, and patterns of comorbidity were remarkably similar internationally.\u201d The aggregate lifetime prevalence of BD-I was 0.6%, BD-II 0.4%, subthreshold BD 1.4%, and bipolar spectrum 2.4%. [2]"}
{"id": "article-18332_11", "title": "Bipolar Disorder -- Epidemiology", "content": "There are two peaks in the age\u00a0of onset: 15-24 years and 45-54 years, with more than 70% of individuals manifesting clinical characteristics of the condition before 25 years of age. [12] [13] Bipolar\u00a0disorder shows a relatively equal distribution across sex, ethnicity, and urban compared to rural areas. [7] [14] Cyclothymia is associated with a lifetime prevalence of approximately 0.4-1% and a male-to-female ratio of 1:1. [15]", "contents": "Bipolar Disorder -- Epidemiology. There are two peaks in the age\u00a0of onset: 15-24 years and 45-54 years, with more than 70% of individuals manifesting clinical characteristics of the condition before 25 years of age. [12] [13] Bipolar\u00a0disorder shows a relatively equal distribution across sex, ethnicity, and urban compared to rural areas. [7] [14] Cyclothymia is associated with a lifetime prevalence of approximately 0.4-1% and a male-to-female ratio of 1:1. [15]"}
{"id": "article-18332_12", "title": "Bipolar Disorder -- Pathophysiology", "content": "As with the etiology, the pathophysiology of\u00a0BD is unknown and is thought to involve interactions between multiple genetic, neurochemical, and environmental factors. A recent neurobiology review article discusses in detail the \u201cgenetic components, signaling pathways, biochemical changes, and neuroimaging findings\u201d in BD. [10]", "contents": "Bipolar Disorder -- Pathophysiology. As with the etiology, the pathophysiology of\u00a0BD is unknown and is thought to involve interactions between multiple genetic, neurochemical, and environmental factors. A recent neurobiology review article discusses in detail the \u201cgenetic components, signaling pathways, biochemical changes, and neuroimaging findings\u201d in BD. [10]"}
{"id": "article-18332_13", "title": "Bipolar Disorder -- Pathophysiology", "content": "Evidence supports a strong genetic component and an epigenetic contribution. Human studies have shown changes in brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) in patients with BD, indicating neurotrophic signaling is a molecular mechanism associated with decreased neuroplasticity. Other proposed mechanisms include mitochondrial dysfunction, oxidative stress, immune-inflammatory imbalance, and compromised hypothalamic-pituitary-adrenal axis. Additionally, neuroimaging studies have shown \u201cevidence of change in regional activity, functional connectivity, neuronal activity, and bioenergetics associated with BD,\u201d\u00a0and anatomic studies have revealed dendritic spine loss in the dorsolateral prefrontal cortex in the post-mortem brain tissue of patients with BD. [10] [16]", "contents": "Bipolar Disorder -- Pathophysiology. Evidence supports a strong genetic component and an epigenetic contribution. Human studies have shown changes in brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) in patients with BD, indicating neurotrophic signaling is a molecular mechanism associated with decreased neuroplasticity. Other proposed mechanisms include mitochondrial dysfunction, oxidative stress, immune-inflammatory imbalance, and compromised hypothalamic-pituitary-adrenal axis. Additionally, neuroimaging studies have shown \u201cevidence of change in regional activity, functional connectivity, neuronal activity, and bioenergetics associated with BD,\u201d\u00a0and anatomic studies have revealed dendritic spine loss in the dorsolateral prefrontal cortex in the post-mortem brain tissue of patients with BD. [10] [16]"}
{"id": "article-18332_14", "title": "Bipolar Disorder -- Pathophysiology", "content": "As mentioned, imbalances in systems associated with monoaminergic neurotransmitters, particularly dopamine and serotonin, and intracellular signaling systems that regulate mood are thought to be involved. However, no singular dysfunction of these neurotransmitter systems has been identified. [8]", "contents": "Bipolar Disorder -- Pathophysiology. As mentioned, imbalances in systems associated with monoaminergic neurotransmitters, particularly dopamine and serotonin, and intracellular signaling systems that regulate mood are thought to be involved. However, no singular dysfunction of these neurotransmitter systems has been identified. [8]"}
{"id": "article-18332_15", "title": "Bipolar Disorder -- History and Physical", "content": "Because bipolar disorder is a clinical diagnosis, making the correct diagnosis requires a comprehensive clinical assessment, including the directed patient interview, preferably supplemented by interviews of their relatives and the longitudinal course of their condition. Currently, there is no biomarker or neuroimaging study to aid in making the diagnosis.", "contents": "Bipolar Disorder -- History and Physical. Because bipolar disorder is a clinical diagnosis, making the correct diagnosis requires a comprehensive clinical assessment, including the directed patient interview, preferably supplemented by interviews of their relatives and the longitudinal course of their condition. Currently, there is no biomarker or neuroimaging study to aid in making the diagnosis."}
{"id": "article-18332_16", "title": "Bipolar Disorder -- History and Physical", "content": "Most patients with bipolar disorder are not correctly diagnosed until approximately 6 to 10 years after first contact with a healthcare provider, despite the presence of clinical characteristics of the condition. [17] Notably, misdiagnosing BD after first contact differs from not recognizing the transition from major depressive disorder (MDD), the most common index presentation, to BD. Estimates of patients transitioning to BD within three years of an MDD diagnosis range from 20-30%; therefore, clinicians must maintain an awareness of the potential for this transition when caring for patients with MDD who initially screened negative for BD. [18] Also, subthreshold hypomanic symptoms can occur in as many as 40% of patients with MDD. [19]", "contents": "Bipolar Disorder -- History and Physical. Most patients with bipolar disorder are not correctly diagnosed until approximately 6 to 10 years after first contact with a healthcare provider, despite the presence of clinical characteristics of the condition. [17] Notably, misdiagnosing BD after first contact differs from not recognizing the transition from major depressive disorder (MDD), the most common index presentation, to BD. Estimates of patients transitioning to BD within three years of an MDD diagnosis range from 20-30%; therefore, clinicians must maintain an awareness of the potential for this transition when caring for patients with MDD who initially screened negative for BD. [18] Also, subthreshold hypomanic symptoms can occur in as many as 40% of patients with MDD. [19]"}
{"id": "article-18332_17", "title": "Bipolar Disorder -- History and Physical", "content": "Although not highly sensitive and specific, self-report screening tools for BD may aid clinicians in making an accurate diagnosis. The most studied screening tools are the Mood Disorders Questionnaire (sensitivity 80%, specificity 70%) and the Hypomania Checklist 32 (sensitivity 82%, specificity 57%). [20] Positive results should motivate the clinician to conduct a thorough clinical assessment for bipolar disorder.", "contents": "Bipolar Disorder -- History and Physical. Although not highly sensitive and specific, self-report screening tools for BD may aid clinicians in making an accurate diagnosis. The most studied screening tools are the Mood Disorders Questionnaire (sensitivity 80%, specificity 70%) and the Hypomania Checklist 32 (sensitivity 82%, specificity 57%). [20] Positive results should motivate the clinician to conduct a thorough clinical assessment for bipolar disorder."}
{"id": "article-18332_18", "title": "Bipolar Disorder -- History and Physical", "content": "A significant diagnostic challenge is distinguishing between unipolar and bipolar depression because episodes of unipolar major depression and bipolar depression have the same general diagnostic criteria. Clinicians\u00a0must inquire about past manic, hypomanic, and depressive episodes in patients presenting with symptoms of a depressive episode. Inquiry into past hypomanic or manic episodes is particularly important for patients with early onset of their first depressive episode (ie, in patients younger than 25 years), a high number of lifetime depressive episodes (5 or more episodes), and a family history of bipolar disorder. These findings in the patient\u2019s history have been shown to increase the likelihood of a bipolar rather than a unipolar diagnosis. [21]", "contents": "Bipolar Disorder -- History and Physical. A significant diagnostic challenge is distinguishing between unipolar and bipolar depression because episodes of unipolar major depression and bipolar depression have the same general diagnostic criteria. Clinicians\u00a0must inquire about past manic, hypomanic, and depressive episodes in patients presenting with symptoms of a depressive episode. Inquiry into past hypomanic or manic episodes is particularly important for patients with early onset of their first depressive episode (ie, in patients younger than 25 years), a high number of lifetime depressive episodes (5 or more episodes), and a family history of bipolar disorder. These findings in the patient\u2019s history have been shown to increase the likelihood of a bipolar rather than a unipolar diagnosis. [21]"}
{"id": "article-18332_19", "title": "Bipolar Disorder -- History and Physical", "content": "Other factors increasing the likelihood of a diagnostic change from MDD to BD include the presence of psychosis, unresponsiveness to antidepressants, the induction of manic or hypomanic symptoms by antidepressant drug treatment, and polymorbidity, defined as\u00a03 or more comorbid conditions. [18] [22]", "contents": "Bipolar Disorder -- History and Physical. Other factors increasing the likelihood of a diagnostic change from MDD to BD include the presence of psychosis, unresponsiveness to antidepressants, the induction of manic or hypomanic symptoms by antidepressant drug treatment, and polymorbidity, defined as\u00a03 or more comorbid conditions. [18] [22]"}
{"id": "article-18332_20", "title": "Bipolar Disorder -- Evaluation", "content": "General\u00a0DSM-5 Diagnostic Criteria for Bipolar and Related Disorders (American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders\u00a05th edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013)", "contents": "Bipolar Disorder -- Evaluation. General\u00a0DSM-5 Diagnostic Criteria for Bipolar and Related Disorders (American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders\u00a05th edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013)"}
{"id": "article-18332_21", "title": "Bipolar Disorder -- Evaluation", "content": "BD-I : Criteria met for at least one manic episode, which might have been preceded or followed by a hypomanic episode or major depressive episode (hypomanic or major depressive episodes\u00a0are\u00a0not required for the diagnosis). BD-II : Criteria met for at least one current or past hypomanic episode and a major depressive episode; no manic episodes.", "contents": "Bipolar Disorder -- Evaluation. BD-I : Criteria met for at least one manic episode, which might have been preceded or followed by a hypomanic episode or major depressive episode (hypomanic or major depressive episodes\u00a0are\u00a0not required for the diagnosis). BD-II : Criteria met for at least one current or past hypomanic episode and a major depressive episode; no manic episodes."}
{"id": "article-18332_22", "title": "Bipolar Disorder -- Evaluation", "content": "Cyclothymic disorder : Hypomanic symptoms that do not meet the criteria for hypomanic episodes and depressive symptoms that do not meet the criteria for major depressive episodes in numerousperiods (at least half the time) for at least\u00a02 years (1 year in those aged \u226418 years); criteria for major depressive, manic, or hypomanic episodes have never been met.", "contents": "Bipolar Disorder -- Evaluation. Cyclothymic disorder : Hypomanic symptoms that do not meet the criteria for hypomanic episodes and depressive symptoms that do not meet the criteria for major depressive episodes in numerousperiods (at least half the time) for at least\u00a02 years (1 year in those aged \u226418 years); criteria for major depressive, manic, or hypomanic episodes have never been met."}
{"id": "article-18332_23", "title": "Bipolar Disorder -- Evaluation", "content": "Specified bipolar and related disorders : Bipolar-like phenomena that do not\u00a0meet the criteria for\u00a0BD-I,\u00a0BD-II,\u00a0or cyclothymic disorder due to insufficient duration or severity, ie, 1) short-duration hypomanic episodes and major depressive disorder, 2) hypomanic episodes with insufficient symptoms and major depressive episode, 3) hypomanic\u00a0episode without a prior major depressive episode, and 4) short-duration cyclothymia.", "contents": "Bipolar Disorder -- Evaluation. Specified bipolar and related disorders : Bipolar-like phenomena that do not\u00a0meet the criteria for\u00a0BD-I,\u00a0BD-II,\u00a0or cyclothymic disorder due to insufficient duration or severity, ie, 1) short-duration hypomanic episodes and major depressive disorder, 2) hypomanic episodes with insufficient symptoms and major depressive episode, 3) hypomanic\u00a0episode without a prior major depressive episode, and 4) short-duration cyclothymia."}
{"id": "article-18332_24", "title": "Bipolar Disorder -- Evaluation", "content": "Unspecified bipolar and related disorders : Characteristic symptoms of bipolar and related disorders that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning but do not meet the\u00a0full criteria for any category previously mentioned. The symptoms and episodes used to diagnose these disorders must not be related to the physiological effects of a substance or general medical condition.", "contents": "Bipolar Disorder -- Evaluation. Unspecified bipolar and related disorders : Characteristic symptoms of bipolar and related disorders that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning but do not meet the\u00a0full criteria for any category previously mentioned. The symptoms and episodes used to diagnose these disorders must not be related to the physiological effects of a substance or general medical condition."}
{"id": "article-18332_25", "title": "Bipolar Disorder -- Evaluation", "content": "BD-I and BD-II can be further specified as rapid cycling or seasonal patterns and whether the episodes have psychotic features, catatonia, anxious distress, melancholic features, or peripartum onset. Rapid cycling refers to\u00a04 or more distinct mood episodes during a 12-month period.", "contents": "Bipolar Disorder -- Evaluation. BD-I and BD-II can be further specified as rapid cycling or seasonal patterns and whether the episodes have psychotic features, catatonia, anxious distress, melancholic features, or peripartum onset. Rapid cycling refers to\u00a04 or more distinct mood episodes during a 12-month period."}
{"id": "article-18332_26", "title": "Bipolar Disorder -- Evaluation", "content": "Mood-congruent delusions may be present in either\u00a0a depressive or manic\u00a0episode, including delusions of guilt or grandiose delusions of power and wealth. Psychotic features, by definition, are absent in hypomanic episodes.", "contents": "Bipolar Disorder -- Evaluation. Mood-congruent delusions may be present in either\u00a0a depressive or manic\u00a0episode, including delusions of guilt or grandiose delusions of power and wealth. Psychotic features, by definition, are absent in hypomanic episodes."}
{"id": "article-18332_27", "title": "Bipolar Disorder -- Evaluation", "content": "To better account for \"mixed features,\" the current diagnostic criteria implements\u00a0specifiers.\u00a0Manic or hypomanic episodes with mixed features meet the full criteria for mania or hypomania and have at least\u00a03 of the following signs or symptoms: depressed mood, anhedonia, psychomotor retardation, fatigue, excessive guilt, or recurrent thoughts of death.\u00a0Major depressive episodes with mixed features meet the full criteria for a major depressive episode and have at least\u00a03 of the following signs or symptoms: expansive mood, grandiosity,\u00a0increased talkativeness, flight of ideas, increased goal-directed activity, indulgence in activities with a high potential for \"painful consequences,\" and decreased need for sleep. The mixed features must be present during \"most days.\"", "contents": "Bipolar Disorder -- Evaluation. To better account for \"mixed features,\" the current diagnostic criteria implements\u00a0specifiers.\u00a0Manic or hypomanic episodes with mixed features meet the full criteria for mania or hypomania and have at least\u00a03 of the following signs or symptoms: depressed mood, anhedonia, psychomotor retardation, fatigue, excessive guilt, or recurrent thoughts of death.\u00a0Major depressive episodes with mixed features meet the full criteria for a major depressive episode and have at least\u00a03 of the following signs or symptoms: expansive mood, grandiosity,\u00a0increased talkativeness, flight of ideas, increased goal-directed activity, indulgence in activities with a high potential for \"painful consequences,\" and decreased need for sleep. The mixed features must be present during \"most days.\""}
{"id": "article-18332_28", "title": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar I Disorder", "content": "For a diagnosis of BD-I, it is necessary to meet the following criteria for a manic episode. The manic episode may have been preceded by and may be followed by hypomanic or major depressive episodes (hypomanic or major depressive episodes\u00a0are\u00a0not required for the diagnosis).", "contents": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar I Disorder. For a diagnosis of BD-I, it is necessary to meet the following criteria for a manic episode. The manic episode may have been preceded by and may be followed by hypomanic or major depressive episodes (hypomanic or major depressive episodes\u00a0are\u00a0not required for the diagnosis)."}
{"id": "article-18332_29", "title": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar I Disorder", "content": "A\u00a0manic episode is defined as a distinct period of persistently elevated or irritable mood with increased activity or energy lasting for at least\u00a07 consecutive days or requiring hospitalization. The presence of\u00a03 or more of the following is required to qualify as a manic episode. If the mood is irritable, at least\u00a04 of the following must be present: Inflated self-esteem or grandiosity Decreased need for sleep A compulsion to keep talking or being more talkative than usual Flight of ideas or racing thoughts High distractibility Increased goal-directed activity (socially, at work or school, or sexually) or psychomotor agitation (non-goal-directed activity) Excessive involvement in activities that have a high potential for painful consequences, such as engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments The episode is not attributable to the physiological effects of a substance or general medical condition.", "contents": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar I Disorder. A\u00a0manic episode is defined as a distinct period of persistently elevated or irritable mood with increased activity or energy lasting for at least\u00a07 consecutive days or requiring hospitalization. The presence of\u00a03 or more of the following is required to qualify as a manic episode. If the mood is irritable, at least\u00a04 of the following must be present: Inflated self-esteem or grandiosity Decreased need for sleep A compulsion to keep talking or being more talkative than usual Flight of ideas or racing thoughts High distractibility Increased goal-directed activity (socially, at work or school, or sexually) or psychomotor agitation (non-goal-directed activity) Excessive involvement in activities that have a high potential for painful consequences, such as engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments The episode is not attributable to the physiological effects of a substance or general medical condition."}
{"id": "article-18332_30", "title": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar I Disorder", "content": "The symptoms of a manic episode are markedly more severe than those of a hypomanic episode and result in impaired social or occupational functioning or require hospitalization.", "contents": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar I Disorder. The symptoms of a manic episode are markedly more severe than those of a hypomanic episode and result in impaired social or occupational functioning or require hospitalization."}
{"id": "article-18332_31", "title": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar II Disorder", "content": "For a diagnosis of BD-II, it is necessary to\u00a0have\u00a0met the criteria for at least one current or past hypomanic episode and a major depressive episode without a manic episode (see below for\u00a0major depressive episode criteria).", "contents": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar II Disorder. For a diagnosis of BD-II, it is necessary to\u00a0have\u00a0met the criteria for at least one current or past hypomanic episode and a major depressive episode without a manic episode (see below for\u00a0major depressive episode criteria)."}
{"id": "article-18332_32", "title": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar II Disorder", "content": "A\u00a0hypomanic episode is defined as a distinct period of persistently elevated or irritable mood with increased activity or energy lasting for at least\u00a04 consecutive days. The presence of\u00a03 or more of the following is required to qualify as a hypomanic episode. If the mood is irritable, at least 4\u00a0of the following must be present: Inflated self-esteem or grandiosity Decreased need for sleep A compulsion to keep talking or being more talkative than usual Flight of ideas or racing thoughts High distractibility Increased goal-directed activity (socially, at work or school, or sexually) or psychomotor agitation (non-goal-directed activity) Excessive involvement in activities that have a high potential for painful consequences, such as engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments", "contents": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar II Disorder. A\u00a0hypomanic episode is defined as a distinct period of persistently elevated or irritable mood with increased activity or energy lasting for at least\u00a04 consecutive days. The presence of\u00a03 or more of the following is required to qualify as a hypomanic episode. If the mood is irritable, at least 4\u00a0of the following must be present: Inflated self-esteem or grandiosity Decreased need for sleep A compulsion to keep talking or being more talkative than usual Flight of ideas or racing thoughts High distractibility Increased goal-directed activity (socially, at work or school, or sexually) or psychomotor agitation (non-goal-directed activity) Excessive involvement in activities that have a high potential for painful consequences, such as engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments"}
{"id": "article-18332_33", "title": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar II Disorder", "content": "The episode is an unequivocal change in functioning, uncharacteristic of\u00a0the person and observable by others. Also, the episode is not severe enough to cause marked impairment, is not due to the physiological effects of a substance or general medical condition, and there is no psychosis (if present, this is mania by definition).", "contents": "Bipolar Disorder -- Evaluation -- DSM-5 Diagnostic Criteria for Bipolar II Disorder. The episode is an unequivocal change in functioning, uncharacteristic of\u00a0the person and observable by others. Also, the episode is not severe enough to cause marked impairment, is not due to the physiological effects of a substance or general medical condition, and there is no psychosis (if present, this is mania by definition)."}
{"id": "article-18332_34", "title": "Bipolar Disorder -- Evaluation -- The presence of\u00a05 or more of the following symptoms daily or nearly every day for a consecutive 2-week period that is a change from baseline or previous functioning:", "content": "Subjective report of depressed mood most of the day (or depressed mood observed by others) Anhedonia most of the day Significant weight loss when not dieting or weight gain or decrease or increase in appetite Insomnia or hypersomnia Psychomotor agitation or retardation Fatigue\u00a0or loss of energy Feelings of worthlessness or excessive or inappropriate guilt Decreased concentration\u00a0or indecisiveness Recurrent thoughts of death, recurrent suicidal ideation without a specific plan", "contents": "Bipolar Disorder -- Evaluation -- The presence of\u00a05 or more of the following symptoms daily or nearly every day for a consecutive 2-week period that is a change from baseline or previous functioning:. Subjective report of depressed mood most of the day (or depressed mood observed by others) Anhedonia most of the day Significant weight loss when not dieting or weight gain or decrease or increase in appetite Insomnia or hypersomnia Psychomotor agitation or retardation Fatigue\u00a0or loss of energy Feelings of worthlessness or excessive or inappropriate guilt Decreased concentration\u00a0or indecisiveness Recurrent thoughts of death, recurrent suicidal ideation without a specific plan"}
{"id": "article-18332_35", "title": "Bipolar Disorder -- Evaluation", "content": "To meet the criteria, at least one of the symptoms must be depressed mood or anhedonia, the symptoms must not be attributable to a\u00a0substance or general medical condition, and it causes functional impairment (eg, social or occupational).", "contents": "Bipolar Disorder -- Evaluation. To meet the criteria, at least one of the symptoms must be depressed mood or anhedonia, the symptoms must not be attributable to a\u00a0substance or general medical condition, and it causes functional impairment (eg, social or occupational)."}
{"id": "article-18332_36", "title": "Bipolar Disorder -- Evaluation -- Possible Secondary Cause of Bipolar Disorder", "content": "The following characteristics may heighten the clinical suspicion for a possible secondary cause in patients with signs and symptoms associated with bipolar disorder:\u00a0older than 50 at the first onset of symptoms, abnormal vital signs or neurological examination, a recent change in health status or medications temporally associated with symptom onset, unusual response or unresponsiveness to appropriate treatments, and no personal or family history of a psychiatric disorder.", "contents": "Bipolar Disorder -- Evaluation -- Possible Secondary Cause of Bipolar Disorder. The following characteristics may heighten the clinical suspicion for a possible secondary cause in patients with signs and symptoms associated with bipolar disorder:\u00a0older than 50 at the first onset of symptoms, abnormal vital signs or neurological examination, a recent change in health status or medications temporally associated with symptom onset, unusual response or unresponsiveness to appropriate treatments, and no personal or family history of a psychiatric disorder."}
{"id": "article-18332_37", "title": "Bipolar Disorder -- Evaluation -- Possible Secondary Cause of Bipolar Disorder", "content": "Recommended initial evaluation for a possible secondary cause includes a urine drug screen, complete blood count with blood smear, comprehensive metabolic panel, thyroid function tests, and vitamin B and folate levels.", "contents": "Bipolar Disorder -- Evaluation -- Possible Secondary Cause of Bipolar Disorder. Recommended initial evaluation for a possible secondary cause includes a urine drug screen, complete blood count with blood smear, comprehensive metabolic panel, thyroid function tests, and vitamin B and folate levels."}
{"id": "article-18332_38", "title": "Bipolar Disorder -- Treatment / Management", "content": "Although numerous clinical practice guidelines exist for the treatment and management of bipolar disorder, there is not enough consistency to generate a \u2018meta-consensus\u2019 model. [23] Authors of a recent systematic review concluded, \u201cThe absence of a uniform language and recommendations in current guidelines may be an additional complicating factor in the implementation of evidence-based treatments in BD.\u201d [24] The following is\u00a0an abbreviated\u00a0synthesis of guidelines published by the National Institute for Health and Care Excellence (NICE), British Association for Psychopharmacology, International College of Neuro-Psychopharmacology (CINP), Canadian Network for Mood and Anxiety Treatments (CANMAT), International Society for Bipolar Disorders (ISBD), and Indian Psychiatric Society (IPS). [25] [26] [27] [28] [29]", "contents": "Bipolar Disorder -- Treatment / Management. Although numerous clinical practice guidelines exist for the treatment and management of bipolar disorder, there is not enough consistency to generate a \u2018meta-consensus\u2019 model. [23] Authors of a recent systematic review concluded, \u201cThe absence of a uniform language and recommendations in current guidelines may be an additional complicating factor in the implementation of evidence-based treatments in BD.\u201d [24] The following is\u00a0an abbreviated\u00a0synthesis of guidelines published by the National Institute for Health and Care Excellence (NICE), British Association for Psychopharmacology, International College of Neuro-Psychopharmacology (CINP), Canadian Network for Mood and Anxiety Treatments (CANMAT), International Society for Bipolar Disorders (ISBD), and Indian Psychiatric Society (IPS). [25] [26] [27] [28] [29]"}
{"id": "article-18332_39", "title": "Bipolar Disorder -- Treatment / Management -- Manic Episode", "content": "Mania is considered a medical emergency and often requires psychiatric hospitalization. Initial treatment is aimed at stabilization of the potentially or acutely agitated patient to help de-escalate distress, mitigate potentially dangerous behavior, and facilitate the patient assessment and evaluation. When possible, a calming environment with minimal stimuli should be provided. Adjunctive benzodiazepines may be used concomitantly with mood stabilizers and antipsychotic drugs to reduce agitation and promote sleep.", "contents": "Bipolar Disorder -- Treatment / Management -- Manic Episode. Mania is considered a medical emergency and often requires psychiatric hospitalization. Initial treatment is aimed at stabilization of the potentially or acutely agitated patient to help de-escalate distress, mitigate potentially dangerous behavior, and facilitate the patient assessment and evaluation. When possible, a calming environment with minimal stimuli should be provided. Adjunctive benzodiazepines may be used concomitantly with mood stabilizers and antipsychotic drugs to reduce agitation and promote sleep."}
{"id": "article-18332_40", "title": "Bipolar Disorder -- Treatment / Management -- Manic Episode", "content": "The patient\u2019s current medications must be considered. For example, a second drug is recommended if\u00a0the patient presents while\u00a0the condition is already managed with lithium monotherapy. Also, antidepressants are usually tapered and discontinued in a manic phase. First-line monotherapy includes a mood stabilizer, such as lithium or valproate, or an antipsychotic, such as aripiprazole, asenapine, cariprazine, quetiapine, or risperidone.", "contents": "Bipolar Disorder -- Treatment / Management -- Manic Episode. The patient\u2019s current medications must be considered. For example, a second drug is recommended if\u00a0the patient presents while\u00a0the condition is already managed with lithium monotherapy. Also, antidepressants are usually tapered and discontinued in a manic phase. First-line monotherapy includes a mood stabilizer, such as lithium or valproate, or an antipsychotic, such as aripiprazole, asenapine, cariprazine, quetiapine, or risperidone."}
{"id": "article-18332_41", "title": "Bipolar Disorder -- Treatment / Management -- Manic Episode", "content": "Add another medication if symptoms are inadequately controlled, or the mania is very severe. Combination treatments include lithium or valproate with either aripiprazole, asenapine, olanzapine, quetiapine, or risperidone. Electroconvulsive therapy (ECT) may be considered as monotherapy or as part of combination therapy in patients whose mania is particularly severe or treatment-resistant and in women with severe mania who are pregnant. Valproate should not be used for women of childbearing potential due to the unacceptable risk to the fetus of teratogenesis and impaired intellectual development.", "contents": "Bipolar Disorder -- Treatment / Management -- Manic Episode. Add another medication if symptoms are inadequately controlled, or the mania is very severe. Combination treatments include lithium or valproate with either aripiprazole, asenapine, olanzapine, quetiapine, or risperidone. Electroconvulsive therapy (ECT) may be considered as monotherapy or as part of combination therapy in patients whose mania is particularly severe or treatment-resistant and in women with severe mania who are pregnant. Valproate should not be used for women of childbearing potential due to the unacceptable risk to the fetus of teratogenesis and impaired intellectual development."}
{"id": "article-18332_42", "title": "Bipolar Disorder -- Treatment / Management -- Hypomanic Episodes", "content": "By definition, hypomanic episodes are not severe enough to cause marked impairment, and there is no psychosis; therefore, these episodes can be managed in an ambulatory setting. Pharmacotherapy is similar to that for mania, but higher doses may be required for the latter.", "contents": "Bipolar Disorder -- Treatment / Management -- Hypomanic Episodes. By definition, hypomanic episodes are not severe enough to cause marked impairment, and there is no psychosis; therefore, these episodes can be managed in an ambulatory setting. Pharmacotherapy is similar to that for mania, but higher doses may be required for the latter."}
{"id": "article-18332_43", "title": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression", "content": "Suicidal and self-harm risk has priority in managing patients with bipolar disorder who present with an acute depressive episode because most suicide deaths in patients with BD occur during this phase. Patients may or may not require hospitalization.", "contents": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression. Suicidal and self-harm risk has priority in managing patients with bipolar disorder who present with an acute depressive episode because most suicide deaths in patients with BD occur during this phase. Patients may or may not require hospitalization."}
{"id": "article-18332_44", "title": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression", "content": "For patients not already taking long-term medication for BD, first-line monotherapy includes quetiapine, olanzapine, or lurasidone (has not been studied in acute bipolar mania). Combination treatment with olanzapine-fluoxetine, lithium plus lamotrigine, and lurasidone plus lithium or valproate may also be considered.", "contents": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression. For patients not already taking long-term medication for BD, first-line monotherapy includes quetiapine, olanzapine, or lurasidone (has not been studied in acute bipolar mania). Combination treatment with olanzapine-fluoxetine, lithium plus lamotrigine, and lurasidone plus lithium or valproate may also be considered."}
{"id": "article-18332_45", "title": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression", "content": "Consider cognitive behavioral therapy (CBT) as an add-on to pharmacotherapy. However, never consider CBT as monotherapy because there is minimal evidence to support psychological treatments without pharmacotherapy in treating acute bipolar depression. Also, consider adding ECT for refractory bipolar depression or as a first-line treatment in the presence of psychotic features and a high risk of suicide.", "contents": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression. Consider cognitive behavioral therapy (CBT) as an add-on to pharmacotherapy. However, never consider CBT as monotherapy because there is minimal evidence to support psychological treatments without pharmacotherapy in treating acute bipolar depression. Also, consider adding ECT for refractory bipolar depression or as a first-line treatment in the presence of psychotic features and a high risk of suicide."}
{"id": "article-18332_46", "title": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression", "content": "For patients presenting with a depressive episode while taking long-term medication (breakthrough episode), make sure their current treatments\u00a0are likely to protect them from a manic relapse (eg, mood stabilizer or antipsychotic). When applicable, check the medication dose, patient adherence, drug-drug interactions, and serum concentrations. Also, inquire about current stressors, alcohol or substance use, and psychosocial intervention\u00a0adherence. Generally, treatment options for BD-II depression are similar to those for BD-I depression.", "contents": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression. For patients presenting with a depressive episode while taking long-term medication (breakthrough episode), make sure their current treatments\u00a0are likely to protect them from a manic relapse (eg, mood stabilizer or antipsychotic). When applicable, check the medication dose, patient adherence, drug-drug interactions, and serum concentrations. Also, inquire about current stressors, alcohol or substance use, and psychosocial intervention\u00a0adherence. Generally, treatment options for BD-II depression are similar to those for BD-I depression."}
{"id": "article-18332_47", "title": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression", "content": "Antidepressant medications should not be used as monotherapy in most patients with bipolar disorder, as available evidence does not support their efficacy, and there is a risk of a switch to mania or mood instability during an episode of bipolar depression. Antidepressants can be administered adjunctively to mood stabilizers (eg, lithium and lamotrigine) and second-generation antipsychotics.", "contents": "Bipolar Disorder -- Treatment / Management -- Acute Bipolar Depression. Antidepressant medications should not be used as monotherapy in most patients with bipolar disorder, as available evidence does not support their efficacy, and there is a risk of a switch to mania or mood instability during an episode of bipolar depression. Antidepressants can be administered adjunctively to mood stabilizers (eg, lithium and lamotrigine) and second-generation antipsychotics."}
{"id": "article-18332_48", "title": "Bipolar Disorder -- Treatment / Management -- Maintenance Treatment", "content": "Most patients with bipolar disorder will require maintenance treatment for many years, possibly lifelong, to prevent recurrent episodes and restore their pre-illness functioning. The current recommendation is for continuous rather than intermittent treatment, with treatments that were effective during the acute phase often continued initially to prevent early relapse. Mood stabilizers and atypical antipsychotics alone or in combination are the mainstays of maintenance pharmacotherapy.", "contents": "Bipolar Disorder -- Treatment / Management -- Maintenance Treatment. Most patients with bipolar disorder will require maintenance treatment for many years, possibly lifelong, to prevent recurrent episodes and restore their pre-illness functioning. The current recommendation is for continuous rather than intermittent treatment, with treatments that were effective during the acute phase often continued initially to prevent early relapse. Mood stabilizers and atypical antipsychotics alone or in combination are the mainstays of maintenance pharmacotherapy."}
{"id": "article-18332_49", "title": "Bipolar Disorder -- Treatment / Management -- Maintenance Treatment", "content": "There is substantial evidence showing lithium monotherapy\u2019s effectiveness against manic, depressive, and mixed relapse. Additionally, lithium is associated with a decreased risk of suicide in patients with BD. Monitoring during treatment, including serum lithium concentrations, is a standard of care.", "contents": "Bipolar Disorder -- Treatment / Management -- Maintenance Treatment. There is substantial evidence showing lithium monotherapy\u2019s effectiveness against manic, depressive, and mixed relapse. Additionally, lithium is associated with a decreased risk of suicide in patients with BD. Monitoring during treatment, including serum lithium concentrations, is a standard of care."}
{"id": "article-18332_50", "title": "Bipolar Disorder -- Treatment / Management -- Maintenance Treatment", "content": "In addition to the individualized pharmacotherapy plan, essential components of maintenance treatment include medication adherence, primary prevention and treatment for psychiatric and medical comorbidities, and psychotherapy when appropriate. Suicidality surveillance is critical throughout the maintenance phase.", "contents": "Bipolar Disorder -- Treatment / Management -- Maintenance Treatment. In addition to the individualized pharmacotherapy plan, essential components of maintenance treatment include medication adherence, primary prevention and treatment for psychiatric and medical comorbidities, and psychotherapy when appropriate. Suicidality surveillance is critical throughout the maintenance phase."}
{"id": "article-18332_51", "title": "Bipolar Disorder -- Differential Diagnosis", "content": "The differential diagnosis of bipolar disorder includes other conditions characterized by depression, impulsivity, mood lability, anxiety, cognitive dysfunction, and psychosis. The most common differential diagnoses are MDD, schizophrenia, anxiety disorders, substance use disorders, borderline personality disorder, and in the pediatric age group, attention-deficit/hyperactivity disorder and oppositional defiant disorder. [18] [30]", "contents": "Bipolar Disorder -- Differential Diagnosis. The differential diagnosis of bipolar disorder includes other conditions characterized by depression, impulsivity, mood lability, anxiety, cognitive dysfunction, and psychosis. The most common differential diagnoses are MDD, schizophrenia, anxiety disorders, substance use disorders, borderline personality disorder, and in the pediatric age group, attention-deficit/hyperactivity disorder and oppositional defiant disorder. [18] [30]"}
{"id": "article-18332_52", "title": "Bipolar Disorder -- Prognosis", "content": "Bipolar disorder is one of the top 10\u00a0leading causes of disability worldwide. [31] A recent meta-analysis showed that patients with\u00a0BD \u201cexperienced reduced life expectancy relative to the general population, with approximately 13 years of potential life lost.\u201d Additionally, patients with bipolar disorder showed a greater reduction in lifespan relative to the general population than patients with common mental health disorders, including anxiety and depressive disorders, and life expectancy was significantly lower in men with BD than in women with BD. [32] A different meta-analysis showed that all-cause mortality in patients with\u00a0BD is double that expected in the general population. Natural deaths occurred over 1.5 times greater in BD, comprised of an \u201calmost double risk of deaths from circulatory illnesses (heart attacks, strokes, etc) and\u00a03 times the risk of deaths from respiratory illness (COPD, asthma, etc).\u201d Unnatural deaths occurred approximately 7\u00a0times more often than in the general population, with an increased suicide risk of approximately 14 times and an increased risk of other violent deaths of almost\u00a04 times. Deaths by all causes studied were similarly increased in men and women. [33] A more recent systematic review of the association between completed suicide and bipolar disorder showed an approximately 20- to 30-fold greater suicide rate in bipolar disorder than in the general population. [34]", "contents": "Bipolar Disorder -- Prognosis. Bipolar disorder is one of the top 10\u00a0leading causes of disability worldwide. [31] A recent meta-analysis showed that patients with\u00a0BD \u201cexperienced reduced life expectancy relative to the general population, with approximately 13 years of potential life lost.\u201d Additionally, patients with bipolar disorder showed a greater reduction in lifespan relative to the general population than patients with common mental health disorders, including anxiety and depressive disorders, and life expectancy was significantly lower in men with BD than in women with BD. [32] A different meta-analysis showed that all-cause mortality in patients with\u00a0BD is double that expected in the general population. Natural deaths occurred over 1.5 times greater in BD, comprised of an \u201calmost double risk of deaths from circulatory illnesses (heart attacks, strokes, etc) and\u00a03 times the risk of deaths from respiratory illness (COPD, asthma, etc).\u201d Unnatural deaths occurred approximately 7\u00a0times more often than in the general population, with an increased suicide risk of approximately 14 times and an increased risk of other violent deaths of almost\u00a04 times. Deaths by all causes studied were similarly increased in men and women. [33] A more recent systematic review of the association between completed suicide and bipolar disorder showed an approximately 20- to 30-fold greater suicide rate in bipolar disorder than in the general population. [34]"}
{"id": "article-18332_53", "title": "Bipolar Disorder -- Complications", "content": "Individuals with bipolar disorder show a markedly increased risk of premature death due to the increased risk of suicide and medical comorbidities, including cardiovascular, respiratory, and endocrine causes. [35] More than half of patients are overweight or obese, which appears to be independent of treatment with weight-promoting psychotropic medications. [36] One-third of patients with bipolar disorder also meet the criteria for metabolic syndrome, which increases the risks of heart disease and stroke. [37] Additionally, attempted suicides are more common among patients with concurrent metabolic syndrome. [37] Comorbid overweight and obesity are associated with a more severe course, an increased lifetime number of depressive and manic episodes, poorer response to pharmacotherapy, and heightened suicide risk. [22] [38] Migraine is also associated with bipolar disorder. [39]", "contents": "Bipolar Disorder -- Complications. Individuals with bipolar disorder show a markedly increased risk of premature death due to the increased risk of suicide and medical comorbidities, including cardiovascular, respiratory, and endocrine causes. [35] More than half of patients are overweight or obese, which appears to be independent of treatment with weight-promoting psychotropic medications. [36] One-third of patients with bipolar disorder also meet the criteria for metabolic syndrome, which increases the risks of heart disease and stroke. [37] Additionally, attempted suicides are more common among patients with concurrent metabolic syndrome. [37] Comorbid overweight and obesity are associated with a more severe course, an increased lifetime number of depressive and manic episodes, poorer response to pharmacotherapy, and heightened suicide risk. [22] [38] Migraine is also associated with bipolar disorder. [39]"}
{"id": "article-18332_54", "title": "Bipolar Disorder -- Complications", "content": "Psychiatric comorbidity is present in 50\u00a0to 70% of patients with BD. Of those diagnosed with the condition, 70% to 90% meet the criteria for generalized anxiety disorder, social anxiety disorder, or panic disorder,\u00a0and 30\u00a0to 50% for alcohol and other substance use disorders. [40] [41] [42] Psychiatric comorbidities in patients with bipolar disorder are associated with a more severe course, more frequent depressive and manic episodes, and reduced quality of life. [22] Up to half of patients with\u00a0BD have a comorbid personality disorder, particularly borderline personality disorder, and 10\u00a0to 20% have a binge eating disorder, leading to more frequent mood episodes and higher rates of suicidality and alcohol and substance use disorders. [43] [44]", "contents": "Bipolar Disorder -- Complications. Psychiatric comorbidity is present in 50\u00a0to 70% of patients with BD. Of those diagnosed with the condition, 70% to 90% meet the criteria for generalized anxiety disorder, social anxiety disorder, or panic disorder,\u00a0and 30\u00a0to 50% for alcohol and other substance use disorders. [40] [41] [42] Psychiatric comorbidities in patients with bipolar disorder are associated with a more severe course, more frequent depressive and manic episodes, and reduced quality of life. [22] Up to half of patients with\u00a0BD have a comorbid personality disorder, particularly borderline personality disorder, and 10\u00a0to 20% have a binge eating disorder, leading to more frequent mood episodes and higher rates of suicidality and alcohol and substance use disorders. [43] [44]"}
{"id": "article-18332_55", "title": "Bipolar Disorder -- Deterrence and Patient Education", "content": "Psychoeducation delivered individually or in a group setting is recommended for patients and family members and may include teaching to detect and manage prodromes of depression and mania, enhance medication adherence, and improve lifestyle choices. Patients are encouraged to avoid stimulants like caffeine, minimize alcohol consumption, exercise regularly, and practice appropriate sleep hygiene. [28] Providers are encouraged to maximize the therapeutic alliance, convey empathy, allow patients to participate in treatment decisions, and consistently monitor symptoms, which have been shown to reduce suicidal ideation, improve treatment outcomes, and increase patient satisfaction with care. [28] [45] Patients may also benefit from case management or care coordination services to help connect them to community-based resources, such as support groups, mental health centers, and substance use treatment programs.", "contents": "Bipolar Disorder -- Deterrence and Patient Education. Psychoeducation delivered individually or in a group setting is recommended for patients and family members and may include teaching to detect and manage prodromes of depression and mania, enhance medication adherence, and improve lifestyle choices. Patients are encouraged to avoid stimulants like caffeine, minimize alcohol consumption, exercise regularly, and practice appropriate sleep hygiene. [28] Providers are encouraged to maximize the therapeutic alliance, convey empathy, allow patients to participate in treatment decisions, and consistently monitor symptoms, which have been shown to reduce suicidal ideation, improve treatment outcomes, and increase patient satisfaction with care. [28] [45] Patients may also benefit from case management or care coordination services to help connect them to community-based resources, such as support groups, mental health centers, and substance use treatment programs."}
{"id": "article-18332_56", "title": "Bipolar Disorder -- Enhancing Healthcare Team Outcomes", "content": "The goal of treatment for patients with bipolar disorder is a full functional recovery (a return to pre-illness baseline functioning). This goal can best be achieved by integrating psychiatric and medical healthcare\u00a0using an interprofessional team approach to manage\u00a0BD and comorbid psychiatric and medical conditions. [46] Interprofessional healthcare teams may consist of any combination of the following: case manager, primary care clinician, psychiatrist, psychiatric nurse practitioner, psychiatric physician assistant, psychiatric nurse specialist, social worker, psychologist, and pharmacist.", "contents": "Bipolar Disorder -- Enhancing Healthcare Team Outcomes. The goal of treatment for patients with bipolar disorder is a full functional recovery (a return to pre-illness baseline functioning). This goal can best be achieved by integrating psychiatric and medical healthcare\u00a0using an interprofessional team approach to manage\u00a0BD and comorbid psychiatric and medical conditions. [46] Interprofessional healthcare teams may consist of any combination of the following: case manager, primary care clinician, psychiatrist, psychiatric nurse practitioner, psychiatric physician assistant, psychiatric nurse specialist, social worker, psychologist, and pharmacist."}
{"id": "article-18332_57", "title": "Bipolar Disorder -- Enhancing Healthcare Team Outcomes", "content": "Ideally, a consistent long-term alliance will form between the patient, their family, and healthcare team members to provide pharmacotherapy management, psychoeducation, ongoing monitoring, and psychosocial support. [26] Also, patients with bipolar disorder and co-occurring alcohol or substance use disorders may benefit from the involvement of an addiction specialist, as there is evidence that effective treatment can improve outcomes. [47] Pharmacists must perform medication reconciliation to ensure there are no drug-drug interactions that could inhibit effective care and report any concerns they have to the prescriber or their nursing staff. Furthermore, collaborative care models have shown efficacy in improving outcomes when used to treat patients with BD. Key elements include patient psychoeducation, using evidence-based treatment guidelines; collaborative decision-making by patients and their healthcare provider(s); and supportive technology to support monitoring and patient follow-up. [46] [48] [49]", "contents": "Bipolar Disorder -- Enhancing Healthcare Team Outcomes. Ideally, a consistent long-term alliance will form between the patient, their family, and healthcare team members to provide pharmacotherapy management, psychoeducation, ongoing monitoring, and psychosocial support. [26] Also, patients with bipolar disorder and co-occurring alcohol or substance use disorders may benefit from the involvement of an addiction specialist, as there is evidence that effective treatment can improve outcomes. [47] Pharmacists must perform medication reconciliation to ensure there are no drug-drug interactions that could inhibit effective care and report any concerns they have to the prescriber or their nursing staff. Furthermore, collaborative care models have shown efficacy in improving outcomes when used to treat patients with BD. Key elements include patient psychoeducation, using evidence-based treatment guidelines; collaborative decision-making by patients and their healthcare provider(s); and supportive technology to support monitoring and patient follow-up. [46] [48] [49]"}
{"id": "article-18332_58", "title": "Bipolar Disorder -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional approach is a mainstay in treating patients with bipolar disorder.\u00a0An interprofessional team that provides a holistic and integrated approach to patient care can help achieve the best possible outcomes with the fewest adverse events. [Level 5]", "contents": "Bipolar Disorder -- Enhancing Healthcare Team Outcomes. An interprofessional approach is a mainstay in treating patients with bipolar disorder.\u00a0An interprofessional team that provides a holistic and integrated approach to patient care can help achieve the best possible outcomes with the fewest adverse events. [Level 5]"}
{"id": "article-18332_59", "title": "Bipolar Disorder -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Bipolar Disorder -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}